Jeanmarie Perrone, MD, FACMT

Attending Physician, Department of Emergency Medicine
Division of Medical Toxicology
Perelman School of Medicine, University of Pennsylvania

Fellowship: NYU/Bellevue, Medical Toxicology
Residency: Thomas Jefferson University
Medical school: University of Maryland School of Medicine

48-1 Buprenorphine for OUD.jpg
A 2015 study showed that when patients with opioid use disorder were started on buprenorphine with a behavioral intervention in the ED, they were 80% more likely to remain in treatment at 30 days.